We observed that MTHFR and DNMT3A promoters show different methylation levels between blood and tumor tissue; this data was observed in the total population composed of 69 patients as well as in the smaller subgroup of 44 patients for whom healthy thymic specimens were available. The gene discussed is DNMT3A; the disease is neoplasm.